Treatment as Prevention for Hepatitis C in Iceland
ConditionHepatitis C
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLandspitali University Hospital
About this trial
The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.
Eligibility criteria
Qualifiers
HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.
Disqualifiers
Age under 18 years
Inability to sign informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Landspitali University Hospital
Lead sponsor
National Center of Addiction Medicine (SAA)
Collaborator
Source ClinicalTrials.gov